ResMed Inc. (RSMDF) Gross margin 2017–2026
ResMed Inc. (RSMDF) gross margin by fiscal year — reported gross profit divided by reported revenue.
61.1%FY2026 · since FY2017: 58.1% → 61.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 61.1% | +1.7 pp |
| FY2025 | 59.4% | +2.7 pp |
| FY2024 | 56.7% | +0.9 pp |
| FY2023 | 55.8% | -0.8 pp |
| FY2022 | 56.6% | -1.0 pp |
| FY2021 | 57.5% | -0.6 pp |
| FY2020 | 58.1% | +0.8 pp |
| FY2019 | 57.3% | +0.3 pp |
| FY2018 | 57.0% | -1.1 pp |
| FY2017 | 58.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RSMDF financial trends
RSMDF RevenueRSMDF Net incomeRSMDF Net marginRSMDF Gross profitRSMDF Operating incomeRSMDF Operating marginRSMDF Operating cash flowRSMDF Free cash flowRSMDF Capital expendituresRSMDF Return on equityRSMDF Stock buybacksRSMDF Dividends paidRSMDF Total assetsRSMDF Total liabilitiesRSMDF Shareholders’ equityRSMDF overview →